Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Suvorexant-D6 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™

Certified reference material

Manufacturer:  MILLIPORE SUPELCO RED S1151ML

Catalog No. 01-002-010


Due to product restrictions, please to purchase or view availability for this product.


Description

Description

Suvorexant, sold under the trade name Belsomra, is a medication for the treatment of insomnia, approved for sale by the U.S. Food and Drug Administration (FDA) in 2014. The U.S. Drug Enforcement Administration (DEA) has scheduled this substance as controlled substance, as it may lead to physical or psychological dependence. This stable-labeled internal standard is suitable for use in quantitation of suvorexant levels by GC/MS or LC/MS for applications in clinical toxicology, therapeutic drug monitoring or urine drug testing.
Specifications

Specifications

67-56-1
UN 1230 - class 3 - PG 2 - Methanol, solution
456.96
-20°C
9.7°C (49.5°F) - closed cup
C23H17D6ClN6O2
100 μg/mL in methanol
Ampule
1 mL
Safety and Handling

Safety and Handling

H331-H370

H311

SDS
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

CERILLIANT is a registered trademark of Cerilliant Corporation